Skip to main content
Top
Published in: BMC Cancer 1/2008

Open Access 01-12-2008 | Research article

Conjugated linoleic acid induces apoptosis through estrogen receptor alpha in human breast tissue

Authors: Li-Shu Wang, Yi-Wen Huang, Suling Liu, Pearlly Yan, Young C Lin

Published in: BMC Cancer | Issue 1/2008

Login to get access

Abstract

Background

Conjugated linoleic acid (CLA), a naturally occurring fatty acid found in ruminant products such as milk and beef, has been shown to possess anti-cancer activities in in vivo animal models and in vitro cell culture systems. In human breast cancer, the overall duration of estrogen exposure is the most important risk factor for developing estrogen-responsive breast cancer. Accordingly, it has been suggested that estrogen exposure reduces apoptosis through the up-regulation of the anti-apoptosis protein, Bcl-2. Bcl-2, an anti-apoptotic protein, regulates apoptosis and plays a crucial role in the development and growth regulation of normal and cancerous cells. Our research interest is to examine the effects of CLA on the induction of apoptosis in human breast tissues.

Methods

The localization of Bcl-2 in both normal and cancerous human breast tissues was determined by immunohistochemical staining and the Bcl-2 protein expression was tested by western blot analysis. Co-culture of epithelial cells and stromal cells was carried out in the presence or absence of CLA to evaluate apoptosis in the context of a cell-cell interaction.

Results

The results showed that both normal and cancerous breast tissues were positive for Bcl-2 staining, which was higher overall in mammary ducts but very low in the surrounding stromal compartment. Interestingly, by quantifying the western blot data, basal Bcl-2 protein levels were higher in normal breast epithelial cells than in cancerous epithelial cells. Furthermore, treatment with 17β-estradiol (E2) stimulated growth and up-regulated Bcl-2 expression in estrogen responsive breast epithelial cells; however, these carcinogenic effects were diminished by either CLA or 4-Hydroxytamoxifen (Tam) and were suppressed further by the combination of CLA and Tam. In both one cell type cultured and co-culture systems, CLA induced cell apoptosis in ERα transfected MDA-MB-231 cells but not in the wild type MDA-MB-231 cells.

Conclusion

These data, therefore, demonstrate that ERα plays important roles in CLA induced apoptosis in human breast tissues.
Appendix
Available only for authorised users
Literature
1.
go back to reference MacDonald HB: Conjugated linoleic acid and disease prevention: a review of current knowledge. J Am Coll Nutr. 2000, 19 (2 Suppl): 111S-118S.CrossRefPubMed MacDonald HB: Conjugated linoleic acid and disease prevention: a review of current knowledge. J Am Coll Nutr. 2000, 19 (2 Suppl): 111S-118S.CrossRefPubMed
2.
go back to reference Ip MM, Masso-Welch PA, Ip C: Prevention of mammary cancer with conjugated linoleic acid: role of the stroma and the epithelium. J Mammary Gland Biol Neoplasia. 2003, 8: 103-118. 10.1023/A:1025739506536.CrossRefPubMed Ip MM, Masso-Welch PA, Ip C: Prevention of mammary cancer with conjugated linoleic acid: role of the stroma and the epithelium. J Mammary Gland Biol Neoplasia. 2003, 8: 103-118. 10.1023/A:1025739506536.CrossRefPubMed
3.
go back to reference De La Torre A, Debiton E, Juanéda P, Durand D, Chardigny JM, Barthomeuf C, Bauchart D, Gruffat D: Beef conjugated linoleic acid isomers reduce human cancer cell growth even when associated with other beef fatty acids. Br J Nutr. 2006, 95: 346-352. 10.1079/BJN20051634.CrossRefPubMed De La Torre A, Debiton E, Juanéda P, Durand D, Chardigny JM, Barthomeuf C, Bauchart D, Gruffat D: Beef conjugated linoleic acid isomers reduce human cancer cell growth even when associated with other beef fatty acids. Br J Nutr. 2006, 95: 346-352. 10.1079/BJN20051634.CrossRefPubMed
4.
go back to reference Hubbard NE, Lim D, Erickson KL: Beef tallow increases the potency of conjugated linoleic acid in the reduction of mouse mammary tumor metastasis. J Nutr. 2006, 136: 88-93.PubMed Hubbard NE, Lim D, Erickson KL: Beef tallow increases the potency of conjugated linoleic acid in the reduction of mouse mammary tumor metastasis. J Nutr. 2006, 136: 88-93.PubMed
5.
go back to reference Wang LS, Huang YW, Sugimoto Y, Liu S, Chang HL, Ye W, Shu S, Lin YC: Effects of breast stromal cells on conjugated linoleic acid (CLA) modulated vascular endothelial growth factor (VEGF) expression in MCF-7 cells. Anticancer Res. 2005, 25: 4061-4068.PubMed Wang LS, Huang YW, Sugimoto Y, Liu S, Chang HL, Ye W, Shu S, Lin YC: Effects of breast stromal cells on conjugated linoleic acid (CLA) modulated vascular endothelial growth factor (VEGF) expression in MCF-7 cells. Anticancer Res. 2005, 25: 4061-4068.PubMed
6.
go back to reference Wang LS, Huang YW, Sugimoto Y, Liu S, Chang HL, Ye W, Shu S, Lin YC: Conjugated linoleic acid (CLA) up-regulates the estrogen-regulated cancer suppressor gene, protein tyrosine phosphatase gamma (PTPG) in human breast cells. Anticancer Res. 2006, 26: 27-34.PubMed Wang LS, Huang YW, Sugimoto Y, Liu S, Chang HL, Ye W, Shu S, Lin YC: Conjugated linoleic acid (CLA) up-regulates the estrogen-regulated cancer suppressor gene, protein tyrosine phosphatase gamma (PTPG) in human breast cells. Anticancer Res. 2006, 26: 27-34.PubMed
7.
go back to reference Wang LS, Huang YW, Liu S, Chang HL, Ye W, Shu S, Sugimoto Y, Funk JA, Smeaks DD, Hill LN, Lin YC: Conjugated linoleic acid (CLA) modulates prostaglandin E2 (PGE2) signaling in canine mammary cells. Anticancer Res. 2006, 26: 889-898.PubMed Wang LS, Huang YW, Liu S, Chang HL, Ye W, Shu S, Sugimoto Y, Funk JA, Smeaks DD, Hill LN, Lin YC: Conjugated linoleic acid (CLA) modulates prostaglandin E2 (PGE2) signaling in canine mammary cells. Anticancer Res. 2006, 26: 889-898.PubMed
8.
go back to reference Luna-More S, Weil B, Bautista D, Garrido E, Florez P, Martinez C: Bcl-2 protein in normal, hyperplastic and neoplastic breast tissues. A metabolite of the putative stem-cell subpopulation of the mammary gland. Histol Histopathol. 2004, 19: 457-463.PubMed Luna-More S, Weil B, Bautista D, Garrido E, Florez P, Martinez C: Bcl-2 protein in normal, hyperplastic and neoplastic breast tissues. A metabolite of the putative stem-cell subpopulation of the mammary gland. Histol Histopathol. 2004, 19: 457-463.PubMed
9.
go back to reference Ali S, Coombes RC: Endocrine-responsive breast cancer and strategies for combating resistance. Nat Rev Cancer. 2002, 2: 101-112. 10.1038/nrc721.CrossRefPubMed Ali S, Coombes RC: Endocrine-responsive breast cancer and strategies for combating resistance. Nat Rev Cancer. 2002, 2: 101-112. 10.1038/nrc721.CrossRefPubMed
10.
go back to reference Johnston SR, Dowsett M: Aromatase inhibitors for breast cancer: lessons from the laboratory. Nat Rev Cancer. 2003, 3: 821-831. 10.1038/nrc1211.CrossRefPubMed Johnston SR, Dowsett M: Aromatase inhibitors for breast cancer: lessons from the laboratory. Nat Rev Cancer. 2003, 3: 821-831. 10.1038/nrc1211.CrossRefPubMed
11.
go back to reference Xie B, Tsao SW, Wong YC: Sex hormone-induced mammary carcinogenesis in the female Noble rats: expression of bcl-2 and bax in hormonal mammary carcinogenesis. Breast Cancer Res Treat. 2000, 61: 45-57. 10.1023/A:1006400732154.CrossRefPubMed Xie B, Tsao SW, Wong YC: Sex hormone-induced mammary carcinogenesis in the female Noble rats: expression of bcl-2 and bax in hormonal mammary carcinogenesis. Breast Cancer Res Treat. 2000, 61: 45-57. 10.1023/A:1006400732154.CrossRefPubMed
12.
go back to reference Schiff R, Massarweh S, Shou J, Osborne CK: Breast cancer endocrine resistance: how growth factor signaling and estrogen receptor coregulators modulate response. Clin Cancer Res. 2003, 9: 447S-454S.PubMed Schiff R, Massarweh S, Shou J, Osborne CK: Breast cancer endocrine resistance: how growth factor signaling and estrogen receptor coregulators modulate response. Clin Cancer Res. 2003, 9: 447S-454S.PubMed
13.
go back to reference Osborne CK: Tamoxifen in the treatment of breast cancer. N Engl J Med. 1998, 339: 1609-1618. 10.1056/NEJM199811263392207.CrossRefPubMed Osborne CK: Tamoxifen in the treatment of breast cancer. N Engl J Med. 1998, 339: 1609-1618. 10.1056/NEJM199811263392207.CrossRefPubMed
14.
go back to reference Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Early Breast Cancer Trialists' Collaborative Group. Lancet. 1992, 339: 71-85.PubMed Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Early Breast Cancer Trialists' Collaborative Group. Lancet. 1992, 339: 71-85.PubMed
15.
go back to reference Vendrell JA, Bieche I, Desmetz C, Badia E, Tozlu S, Nguyen C, Nicolas JC, Lidereau R, Cohen PA: Molecular changes associated with the agonist activity of hydroxy-tamoxifen and the hyper-response to estradiol in hydroxy-tamoxifen-resistant breast cancer cell lines. Endocr Relat Cancer. 2005, 12: 75-92. 10.1677/erc.1.00899.CrossRefPubMed Vendrell JA, Bieche I, Desmetz C, Badia E, Tozlu S, Nguyen C, Nicolas JC, Lidereau R, Cohen PA: Molecular changes associated with the agonist activity of hydroxy-tamoxifen and the hyper-response to estradiol in hydroxy-tamoxifen-resistant breast cancer cell lines. Endocr Relat Cancer. 2005, 12: 75-92. 10.1677/erc.1.00899.CrossRefPubMed
16.
go back to reference Winer EP, Hudis C, Burstein HJ, Chlebowski RT, Ingle JN, Edge SB, Mamounas EP, Gralow J, Goldstein LJ, Pritchard KI, Braun S, Cobleigh MA, Langer AS, Perotti J, Powles TJ, Whelan TJ, Browman GP: American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for women with hormone receptor-positive breast cancer: status report 2002. J Clin Oncol. 2002, 20: 3317-3327. 10.1200/JCO.2002.06.020.CrossRefPubMed Winer EP, Hudis C, Burstein HJ, Chlebowski RT, Ingle JN, Edge SB, Mamounas EP, Gralow J, Goldstein LJ, Pritchard KI, Braun S, Cobleigh MA, Langer AS, Perotti J, Powles TJ, Whelan TJ, Browman GP: American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for women with hormone receptor-positive breast cancer: status report 2002. J Clin Oncol. 2002, 20: 3317-3327. 10.1200/JCO.2002.06.020.CrossRefPubMed
17.
go back to reference Winer EP, Hudis C, Burstein HJ, Wolff AC, Pritchard KI, Ingle JN, Chlebowski RT, Gelber R, Edge SB, Gralow J, Cobleigh MA, Mamounas EP, Goldstein LJ, Whelan TJ, Powles TJ, Bryant J, Perkins C, Perotti J, Braun S, Langer AS, Browman GP, Somerfield MR: American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004. J Clin Oncol. 2005, 23: 619-629. 10.1200/JCO.2005.09.121.CrossRefPubMed Winer EP, Hudis C, Burstein HJ, Wolff AC, Pritchard KI, Ingle JN, Chlebowski RT, Gelber R, Edge SB, Gralow J, Cobleigh MA, Mamounas EP, Goldstein LJ, Whelan TJ, Powles TJ, Bryant J, Perkins C, Perotti J, Braun S, Langer AS, Browman GP, Somerfield MR: American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004. J Clin Oncol. 2005, 23: 619-629. 10.1200/JCO.2005.09.121.CrossRefPubMed
18.
go back to reference Elenbaas B, Weinberg RA: Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation. Exp Cell Res. 2001, 264: 169-184. 10.1006/excr.2000.5133.CrossRefPubMed Elenbaas B, Weinberg RA: Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation. Exp Cell Res. 2001, 264: 169-184. 10.1006/excr.2000.5133.CrossRefPubMed
19.
go back to reference Krtolica A, Parrinello S, Lockett S, Desprez PY, Campisi J: Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging. Proc Natl Acad Sci USA. 2001, 98: 12072-12077. 10.1073/pnas.211053698.CrossRefPubMedPubMedCentral Krtolica A, Parrinello S, Lockett S, Desprez PY, Campisi J: Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging. Proc Natl Acad Sci USA. 2001, 98: 12072-12077. 10.1073/pnas.211053698.CrossRefPubMedPubMedCentral
20.
go back to reference McCann SE, Ip C, Ip MM, McGuire MK, Muti P, Edge SB, Trevisan M, Freudenheim JL: Dietary intake of conjugated linoleic acids and risk of premenopausal and postmenopausal breast cancer, Western New York Exposures and Breast Cancer Study (WEB Study). Cancer Epidemiol Biomarkers Prev. 2004, 13: 1480-1484.PubMed McCann SE, Ip C, Ip MM, McGuire MK, Muti P, Edge SB, Trevisan M, Freudenheim JL: Dietary intake of conjugated linoleic acids and risk of premenopausal and postmenopausal breast cancer, Western New York Exposures and Breast Cancer Study (WEB Study). Cancer Epidemiol Biomarkers Prev. 2004, 13: 1480-1484.PubMed
21.
go back to reference Masso-Welch PA, Zangani D, Ip C, Vaughan MM, Shoemaker S, Ramirez RA, Ip MM: Inhibition of angiogenesis by the cancer chemopreventive agent conjugated linoleic acid. Cancer Res. 2002, 62: 4383-4389.PubMed Masso-Welch PA, Zangani D, Ip C, Vaughan MM, Shoemaker S, Ramirez RA, Ip MM: Inhibition of angiogenesis by the cancer chemopreventive agent conjugated linoleic acid. Cancer Res. 2002, 62: 4383-4389.PubMed
22.
go back to reference Gutierrez MC, Detre S, Johnston S, Mohsin SK, Shou J, Allred DC, Schiff R, Osborne CK, Dowsett M: Molecular changes in tamoxifen-resistant breast cancer: relationship between estrogen receptor, HER-2, and p38 mitogen-activated protein kinase. J Clin Oncol. 2005, 23: 2469-2476. 10.1200/JCO.2005.01.172.CrossRefPubMed Gutierrez MC, Detre S, Johnston S, Mohsin SK, Shou J, Allred DC, Schiff R, Osborne CK, Dowsett M: Molecular changes in tamoxifen-resistant breast cancer: relationship between estrogen receptor, HER-2, and p38 mitogen-activated protein kinase. J Clin Oncol. 2005, 23: 2469-2476. 10.1200/JCO.2005.01.172.CrossRefPubMed
23.
go back to reference Cory S, Adams JM: The Bcl2 family: regulators of the cellular life-or-death switch. Nat Rev Cancer. 2002, 2: 647-656. 10.1038/nrc883.CrossRefPubMed Cory S, Adams JM: The Bcl2 family: regulators of the cellular life-or-death switch. Nat Rev Cancer. 2002, 2: 647-656. 10.1038/nrc883.CrossRefPubMed
24.
go back to reference Tanmahasamut P, Liu J, Hendry LB, Sidell N: Conjugated linoleic acid blocks estrogen signaling in human breast cancer cells. J Nutr. 2004, 134: 674-680.PubMed Tanmahasamut P, Liu J, Hendry LB, Sidell N: Conjugated linoleic acid blocks estrogen signaling in human breast cancer cells. J Nutr. 2004, 134: 674-680.PubMed
25.
go back to reference Majumder B, Wahle KW, Moir S, Schofield A, Choe SN, Farquharson A, Grant I, Heys SD: Conjugated linoleic acids (CLAs) regulate the expression of key apoptotic genes in human breast cancer cells. FASEB J. 2002, 16: 1447-1449.PubMed Majumder B, Wahle KW, Moir S, Schofield A, Choe SN, Farquharson A, Grant I, Heys SD: Conjugated linoleic acids (CLAs) regulate the expression of key apoptotic genes in human breast cancer cells. FASEB J. 2002, 16: 1447-1449.PubMed
26.
go back to reference Somaï S, Chaouat M, Jacob D, Perrot JY, Rostène W, Forgez P, Gompel A: Antiestrogens are pro-apoptotic in normal human breast epithelial cells. Int J Cancer. 2003, 105: 607-612. 10.1002/ijc.11147.CrossRefPubMed Somaï S, Chaouat M, Jacob D, Perrot JY, Rostène W, Forgez P, Gompel A: Antiestrogens are pro-apoptotic in normal human breast epithelial cells. Int J Cancer. 2003, 105: 607-612. 10.1002/ijc.11147.CrossRefPubMed
27.
go back to reference Breitschopf K, Haendeler J, Malchow P, Zeiher AM, Dimmeler S: Posttranslational modification of Bcl-2 facilitates its proteasome-dependent degradation: molecular characterization of the involved signaling pathway. Mol Cell Biol. 2000, 20: 1886-1896. 10.1128/MCB.20.5.1886-1896.2000.CrossRefPubMedPubMedCentral Breitschopf K, Haendeler J, Malchow P, Zeiher AM, Dimmeler S: Posttranslational modification of Bcl-2 facilitates its proteasome-dependent degradation: molecular characterization of the involved signaling pathway. Mol Cell Biol. 2000, 20: 1886-1896. 10.1128/MCB.20.5.1886-1896.2000.CrossRefPubMedPubMedCentral
28.
go back to reference Manabe Y, Toda S, Miyazaki K, Sugihara H: Mature adipocytes, but not preadipocytes, promote the growth of breast carcinoma cells in collagen gel matrix culture through cancer-stromal cell interactions. J Pathol. 2003, 201: 221-228. 10.1002/path.1430.CrossRefPubMed Manabe Y, Toda S, Miyazaki K, Sugihara H: Mature adipocytes, but not preadipocytes, promote the growth of breast carcinoma cells in collagen gel matrix culture through cancer-stromal cell interactions. J Pathol. 2003, 201: 221-228. 10.1002/path.1430.CrossRefPubMed
29.
go back to reference Novaro V, Radisky DC, Ramos Castro NE, Weisz A, Bissell MJ: Malignant mammary cells acquire independence from extracellular context for regulation of estrogen receptor alpha. Clin Cancer Res. 2004, 10: 402S-409S. 10.1158/1078-0432.CCR-031209.CrossRefPubMed Novaro V, Radisky DC, Ramos Castro NE, Weisz A, Bissell MJ: Malignant mammary cells acquire independence from extracellular context for regulation of estrogen receptor alpha. Clin Cancer Res. 2004, 10: 402S-409S. 10.1158/1078-0432.CCR-031209.CrossRefPubMed
30.
go back to reference Yager JD, Davidson NE: Estrogen carcinogenesis in breast cancer. N Engl J Med. 2006, 354: 270-282. 10.1056/NEJMra050776.CrossRefPubMed Yager JD, Davidson NE: Estrogen carcinogenesis in breast cancer. N Engl J Med. 2006, 354: 270-282. 10.1056/NEJMra050776.CrossRefPubMed
31.
go back to reference Durgam VR, Fernandes G: The growth inhibitory effect of conjugated linoleic acid on MCF-7 cells is related to estrogen response system. Cancer Lett. 1997, 116: 121-130. 10.1016/S0304-3835(97)00192-4.CrossRefPubMed Durgam VR, Fernandes G: The growth inhibitory effect of conjugated linoleic acid on MCF-7 cells is related to estrogen response system. Cancer Lett. 1997, 116: 121-130. 10.1016/S0304-3835(97)00192-4.CrossRefPubMed
32.
go back to reference Maggiora M, Bologna M, Cerù MP, Possati L, Angelucci A, Cimini A, Miglietta A, Bozzo F, Margiotta C, Muzio G, Canuto RA: An overview of the effect of linoleic and conjugated-linoleic acids on the growth of several human tumor cell lines. Int J Cancer. 2004, 112: 909-919. 10.1002/ijc.20519.CrossRefPubMed Maggiora M, Bologna M, Cerù MP, Possati L, Angelucci A, Cimini A, Miglietta A, Bozzo F, Margiotta C, Muzio G, Canuto RA: An overview of the effect of linoleic and conjugated-linoleic acids on the growth of several human tumor cell lines. Int J Cancer. 2004, 112: 909-919. 10.1002/ijc.20519.CrossRefPubMed
33.
go back to reference Liu J, Sidell N: Anti-estrogenic Effects of Conjugated Linoleic Acid through Modulation of Estrogen Receptor Phosphorylation. Breast Cancer Res Treat. 2005, 94: 161-169. 10.1007/s10549-005-6942-4.CrossRefPubMed Liu J, Sidell N: Anti-estrogenic Effects of Conjugated Linoleic Acid through Modulation of Estrogen Receptor Phosphorylation. Breast Cancer Res Treat. 2005, 94: 161-169. 10.1007/s10549-005-6942-4.CrossRefPubMed
34.
go back to reference Thompson H, Zhu ZJ, Banni S, Darcy K, Loftus T, Ip C: Morphological and biochemical status of the mammary gland as influenced by conjugated linoleic acid: Implication for a reduction in mammary cancer risk. Cancer Res. 1997, 57: 5067-5072.PubMed Thompson H, Zhu ZJ, Banni S, Darcy K, Loftus T, Ip C: Morphological and biochemical status of the mammary gland as influenced by conjugated linoleic acid: Implication for a reduction in mammary cancer risk. Cancer Res. 1997, 57: 5067-5072.PubMed
35.
go back to reference Ip C, Singh M, Thompson HJ, Scimeca JA: Conjugated linoleic acid suppresses mammary carcinogenesis and proliferative activity of the mammary gland in the rat. Cancer Res. 1994, 54: 1212-1215.PubMed Ip C, Singh M, Thompson HJ, Scimeca JA: Conjugated linoleic acid suppresses mammary carcinogenesis and proliferative activity of the mammary gland in the rat. Cancer Res. 1994, 54: 1212-1215.PubMed
36.
go back to reference Ip C, Banni S, Angioni E, Carta G, McGinley J, Thompson HJ, Barbano D, Bauman D: Conjugated linoleic acid-enriched butter fat alters mammary gland morphogenesis and reduces cancer risk in rats. J Nutr. 1999, 129: 2135-2142.PubMed Ip C, Banni S, Angioni E, Carta G, McGinley J, Thompson HJ, Barbano D, Bauman D: Conjugated linoleic acid-enriched butter fat alters mammary gland morphogenesis and reduces cancer risk in rats. J Nutr. 1999, 129: 2135-2142.PubMed
37.
go back to reference Ip C, Ip MM, Loftus T, Shoemaker S, Shea-Eaton W: Induction of apoptosis by conjugated linoleic acid in cultured mammary tumor cells and premalignant lesions of the rat mammary gland. Cancer Epidemiol Biomarkers Prev. 2000, 9: 689-696.PubMed Ip C, Ip MM, Loftus T, Shoemaker S, Shea-Eaton W: Induction of apoptosis by conjugated linoleic acid in cultured mammary tumor cells and premalignant lesions of the rat mammary gland. Cancer Epidemiol Biomarkers Prev. 2000, 9: 689-696.PubMed
38.
go back to reference Ioachim EE, Malamou-Mitsi V, Kamina SA, Goussia AC, Agnantis NJ: Immunohistochemical expression of Bcl-2 protein in breast lesions: correlation with Bax, p53, Rb, C-erbB-2, EGFR and proliferation indices. Anticancer Res. 2000, 20: 4221-4225.PubMed Ioachim EE, Malamou-Mitsi V, Kamina SA, Goussia AC, Agnantis NJ: Immunohistochemical expression of Bcl-2 protein in breast lesions: correlation with Bax, p53, Rb, C-erbB-2, EGFR and proliferation indices. Anticancer Res. 2000, 20: 4221-4225.PubMed
39.
go back to reference Kobayashi S, Iwase H, Ito Y, Yamashita H, Iwata H, Yamashita T, Ito K, Toyama T, Nakamura T, Masaoka A: Clinical significance of bcl-2 gene expression in human breast cancer tissues. Breast Cancer Res Treat. 1997, 42: 173-181. 10.1023/A:1005760013810.CrossRefPubMed Kobayashi S, Iwase H, Ito Y, Yamashita H, Iwata H, Yamashita T, Ito K, Toyama T, Nakamura T, Masaoka A: Clinical significance of bcl-2 gene expression in human breast cancer tissues. Breast Cancer Res Treat. 1997, 42: 173-181. 10.1023/A:1005760013810.CrossRefPubMed
40.
go back to reference Nathan B, Gusterson B, Jadayel D, O'Hare M, Anbazhagan R, Jayatilake H, Ebbs S, Micklem K, Price K, Gelber R: Expression of BCL-2 in primary breast cancer and its correlation with tumour phenotype. For the International (Ludwig) Breast Cancer Study Group. Ann Oncol. 1994, 5: 409-414.PubMed Nathan B, Gusterson B, Jadayel D, O'Hare M, Anbazhagan R, Jayatilake H, Ebbs S, Micklem K, Price K, Gelber R: Expression of BCL-2 in primary breast cancer and its correlation with tumour phenotype. For the International (Ludwig) Breast Cancer Study Group. Ann Oncol. 1994, 5: 409-414.PubMed
41.
go back to reference Elenbaas B, Weinberg RA: Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation. Exp Cell Res. 2001, 264: 169-184. 10.1006/excr.2000.5133.CrossRefPubMed Elenbaas B, Weinberg RA: Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation. Exp Cell Res. 2001, 264: 169-184. 10.1006/excr.2000.5133.CrossRefPubMed
42.
go back to reference Krtolica A, Parrinello S, Lockett S, Desprez PY, Campisi J: Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging. Proc Natl Acad Sci USA. 2001, 98: 12072-12077. 10.1073/pnas.211053698.CrossRefPubMedPubMedCentral Krtolica A, Parrinello S, Lockett S, Desprez PY, Campisi J: Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging. Proc Natl Acad Sci USA. 2001, 98: 12072-12077. 10.1073/pnas.211053698.CrossRefPubMedPubMedCentral
43.
go back to reference Ip C, Singh M, Thompson HJ, Scimeca JA: Conjugated linoleic acid suppresses mammary carcinogenesis and proliferative activity of the mammary gland in the rat. Cancer Res. 1994, 54: 1212-1215.PubMed Ip C, Singh M, Thompson HJ, Scimeca JA: Conjugated linoleic acid suppresses mammary carcinogenesis and proliferative activity of the mammary gland in the rat. Cancer Res. 1994, 54: 1212-1215.PubMed
44.
go back to reference Masso-Welch PA, Zangani D, Ip C, Vaughan MM, Shoemaker SF, McGee SO, Ip MM: Isomers of conjugated linoleic acid differ in their effects on angiogenesis and survival of mouse mammary adipose vasculature. J Nutr. 2004, 134: 299-307.PubMed Masso-Welch PA, Zangani D, Ip C, Vaughan MM, Shoemaker SF, McGee SO, Ip MM: Isomers of conjugated linoleic acid differ in their effects on angiogenesis and survival of mouse mammary adipose vasculature. J Nutr. 2004, 134: 299-307.PubMed
45.
go back to reference Aro A, Mannisto S, Salminen I, Ovaskainen ML, Kataja V, Uusitupa M: Inverse association between dietary and serum conjugated linoleic acid and risk of breast cancer in postmenopausal women. Nutr Cancer. 2000, 38: 151-157. 10.1207/S15327914NC382_2.CrossRefPubMed Aro A, Mannisto S, Salminen I, Ovaskainen ML, Kataja V, Uusitupa M: Inverse association between dietary and serum conjugated linoleic acid and risk of breast cancer in postmenopausal women. Nutr Cancer. 2000, 38: 151-157. 10.1207/S15327914NC382_2.CrossRefPubMed
Metadata
Title
Conjugated linoleic acid induces apoptosis through estrogen receptor alpha in human breast tissue
Authors
Li-Shu Wang
Yi-Wen Huang
Suling Liu
Pearlly Yan
Young C Lin
Publication date
01-12-2008
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2008
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/1471-2407-8-208

Other articles of this Issue 1/2008

BMC Cancer 1/2008 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine